Sunday, August 30, 2026 • 02:04 AM
Post-Surgery Pain Drug Pipeline Gains Momentum as 45 Companies Advance New Treatments Drug Discovery and Development
Post-Surgery Pain Drug Pipeline Gains Momentum as 45 Companies Advance New Treatments

By Editorial Panel, Pharma Business Outlook, Editor

CVS Health Expands Weight Management Services with Easier Access and Personalized Care Pharmacy Management
CVS Health Expands Weight Management Services with Easier Access and Personalized Care

By Editorial Panel, Pharma Business Outlook, Editor

Combination Therapy Shows Promise for Better Allergy Relief Clinical Trial Management
Combination Therapy Shows Promise for Better Allergy Relief

By Editorial Panel, Pharma Business Outlook, Editor

AI Powers the Next Wave of Drug Discovery as Bristol Myers Squibb Expands NVIDIA Partnership Drug Discovery and Development
AI Powers the Next Wave of Drug Discovery as Bristol Myers Squibb Expands NVIDIA Partnership

By Editorial Panel, Pharma Business Outlook, Editor

Expanding Care Closer to Home as NYU Langone Strengthens South Florida Network Integrated Healthcare
Expanding Care Closer to Home as NYU Langone Strengthens South Florida Network

By Editorial Panel, Pharma Business Outlook, Editor

Icosagen Expands Biologics Campus to Speed Up Drug Discovery and Manufacturing Drug Discovery and Development
Icosagen Expands Biologics Campus to Speed Up Drug Discovery and Manufacturing

By Editorial Panel, Pharma Business Outlook, Editor

AI-Designed Lung Disease Drug Reaches Major Milestone with Phase III Trial Drug Discovery and Development
AI-Designed Lung Disease Drug Reaches Major Milestone with Phase III Trial

By Editorial Panel, Pharma Business Outlook, Editor

Lilly and Abbisko Join Forces to Accelerate the Future of Drug Discovery Drug Discovery and Development
Lilly and Abbisko Join Forces to Accelerate the Future of Drug Discovery

By Editorial Panel, Pharma Business Outlook, Editor

Premier Health Charts a Path Through Compliance Challenges Clinical Trial Management
Premier Health Charts a Path Through Compliance Challenges

By Editorial Panel, Pharma Business Outlook, Editor

Drug Discovery 2026 Gathers Scientific Leaders for Landmark London Conference Drug Discovery and Development
Drug Discovery 2026 Gathers Scientific Leaders for Landmark London Conference

By Editorial Panel, Pharma Business Outlook, Editor

FDA Explores Artificial Intelligence to Strengthen Drug Safety Testing Drug Discovery and Development
FDA Explores Artificial Intelligence to Strengthen Drug Safety Testing

By Editorial Panel, Pharma Business Outlook, Editor

CVS Challenges Tennessee Pharmacy Law in Major Healthcare Industry Battle Pharmacy Management
CVS Challenges Tennessee Pharmacy Law in Major Healthcare Industry Battle

By Editorial Panel, Pharma Business Outlook, Editor

AI in Clinical Trials Faces New Pressure Over Real-Time Safety and Data Accuracy Clinical Trial Management
AI in Clinical Trials Faces New Pressure Over Real-Time Safety and Data Accuracy

By Editorial Panel, Pharma Business Outlook, Editor

J&J’s Heart Pump Study Offers New Hope for High-Risk Cardiac Surgery Patients Clinical Trial Management
J&J’s Heart Pump Study Offers New Hope for High-Risk Cardiac Surgery Patients

By Editorial Panel, Pharma Business Outlook, Editor

Connecting the Dots in Specialty Care Pharmacy Management
Connecting the Dots in Specialty Care

By Editorial Panel, Pharma Business Outlook, Editor

Amazon Steps Into Drug Discovery With an AI-Powered Molecule Design Platform Drug Discovery and Development
Amazon Steps Into Drug Discovery With an AI-Powered Molecule Design Platform

By Editorial Panel, Pharma Business Outlook, Editor

Pharma Business Outlook

Pharma Business Outlook is more than just a publication—it is a bridge that connects pharmaceutical companies, healthcare providers, and key decision-makers. By fostering discussions on regulatory compliance, emerging market opportunities, and digital transformation, the magazine plays a crucial role in shaping the future of the pharmaceutical ecosystem.